83 related articles for article (PubMed ID: 12674334)
1. Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration.
Sumner DR; Turner TM; Cohen M; Losavio P; Urban RM; Nichols EH; McPherson JM
J Bone Miner Res; 2003 Apr; 18(4):730-6. PubMed ID: 12674334
[TBL] [Abstract][Full Text] [Related]
2. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury.
Sumner DR; Turner TM; Urban RM; Leven RM; Hawkins M; Nichols EH; McPherson JM; Galante JO
J Orthop Res; 2001 Jan; 19(1):85-94. PubMed ID: 11332625
[TBL] [Abstract][Full Text] [Related]
3. Depressed bone mineralization following high dose TGF-beta1 application in an orthopedic implant model.
Broderick E; Infanger S; Turner TM; Sumner DR
Calcif Tissue Int; 2005 May; 76(5):379-84. PubMed ID: 15834504
[TBL] [Abstract][Full Text] [Related]
4. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model.
Sumner DR; Turner TM; Urban RM; Turek T; Seeherman H; Wozney JM
J Orthop Res; 2004 Jan; 22(1):58-65. PubMed ID: 14656660
[TBL] [Abstract][Full Text] [Related]
5. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.
Sumner DR; Turner TM; Urban RM; Virdi AS; Inoue N
J Bone Joint Surg Am; 2006 Apr; 88(4):806-17. PubMed ID: 16595471
[TBL] [Abstract][Full Text] [Related]
6. Local application of rhTGF-beta2 enhances peri-implant bone volume and bone-implant contact in a rat model.
De Ranieri A; Virdi AS; Kuroda S; Shott S; Leven RM; Hallab NJ; Sumner DR
Bone; 2005 Jul; 37(1):55-62. PubMed ID: 15869922
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of bone ingrowth by transforming growth factor-beta.
Sumner DR; Turner TM; Purchio AF; Gombotz WR; Urban RM; Galante JO
J Bone Joint Surg Am; 1995 Aug; 77(8):1135-47. PubMed ID: 7642657
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs.
Lind M; Overgaard S; Søballe K; Nguyen T; Ongpipattanakul B; Bünger C
J Orthop Res; 1996 May; 14(3):343-50. PubMed ID: 8676246
[TBL] [Abstract][Full Text] [Related]
9. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
Boyne PJ
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
[TBL] [Abstract][Full Text] [Related]
10. New scaffold for recombinant human bone morphogenetic protein-2.
Kamakura S; Nakajo S; Suzuki O; Sasano Y
J Biomed Mater Res A; 2004 Nov; 71(2):299-307. PubMed ID: 15368218
[TBL] [Abstract][Full Text] [Related]
11. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses.
Arosarena O; Collins W
Orthod Craniofac Res; 2005 Nov; 8(4):267-76. PubMed ID: 16238607
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human transforming growth factor-beta2 dose on bone formation in rat femur titanium implant model.
Sena K; Sumner DR; Virdi AS
J Biomed Mater Res A; 2010 Mar; 92(3):1210-7. PubMed ID: 19322883
[TBL] [Abstract][Full Text] [Related]
13. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats.
Matin K; Senpuku H; Hanada N; Ozawa H; Ejiri S
Int J Oral Maxillofac Implants; 2003; 18(2):211-7. PubMed ID: 12705298
[TBL] [Abstract][Full Text] [Related]
14. BMP-2-regenerated calvarial bone: a biomechanical appraisal in a large animal model.
Cray J; Henderson SE; Smith DM; Kinsella CR; Bykowski M; Cooper GM; Almarza AJ; Losee JE
Ann Plast Surg; 2014 Nov; 73(5):591-7. PubMed ID: 23657046
[TBL] [Abstract][Full Text] [Related]
15. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
[TBL] [Abstract][Full Text] [Related]
16. A pilot study evaluating the effect of recombinant human bone morphogenetic protein-2 and recombinant human beta-nerve growth factor on the healing of Class III furcation defects in dogs.
Yan XZ; Ge SH; Sun QF; Guo HM; Yang PS
J Periodontol; 2010 Sep; 81(9):1289-98. PubMed ID: 20397902
[TBL] [Abstract][Full Text] [Related]
17. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 (rhGDF-5) in an absorbable collagen sponge carrier into one-wall intrabony defects in dogs: a dose-range study.
Kim TG; Wikesjö UM; Cho KS; Chai JK; Pippig SD; Siedler M; Kim CK
J Clin Periodontol; 2009 Jul; 36(7):589-97. PubMed ID: 19538332
[TBL] [Abstract][Full Text] [Related]
18. Alveolar ridge repair in a canine model using rhTGF-beta 1 with barrier membranes.
Ruskin JD; Hardwick R; Buser D; Dahlin C; Schenk RK
Clin Oral Implants Res; 2000 Apr; 11(2):107-15. PubMed ID: 11168201
[TBL] [Abstract][Full Text] [Related]
19. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration.
Selvig KA; Sorensen RG; Wozney JM; Wikesjö UM
J Periodontol; 2002 Sep; 73(9):1020-9. PubMed ID: 12296587
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model.
Sciadini MF; Johnson KD
J Orthop Res; 2000 Mar; 18(2):289-302. PubMed ID: 10815831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
